Skip to content
POM-V Prescription Required Companion Animal

Pimocard 1.25 mg Flavoured Tablets for Dogs

Active ingredient: Pimobendan

Form

Tablet

Species

Dogs

Manufacturer

Eurovet Animal Health B.V.

VMD MA No.

16849/3019

What it's used for

For the treatment of canine congestive heart failure originating from valvular insufficiency (mitral and/or tricuspid regurgitation) or dilated cardiomyopa...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Pimobendan

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Pimocard 1.25 mg Flavoured Tablets for Dogs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

For the treatment of canine congestive heart failure originating from valvular insufficiency
(mitral and/or tricuspid regurgitation) or dilated cardiomyopathy.
Do not exceed the recommended dosage.
Determine the body weight accurately before treatment to ensure correct dosage.
The tablets should be administered orally at a dose range of 0.2 mg to 0.6 mg
pimobendan/kg body weight per day. The preferable daily dose is 0.5 mg
pimobendan/kg body weight. The dose should be divided into two administrations (0.25
mg/kg body weight each), one half of the dose in the morning and the other half
approximately 12 hours later. Each dose should be given approximately one hour
before feeding.
The product may be combined with a diuretic treatment such as furosemide.
To break a single scored tablet into two halves, place
the tablet on an even surface with the scored side up.
Hold one half of the tablet and press down on the other
half.
Do not use pimobendan in hypertrophic cardiomyopathies or in diseases in which an
improvement in cardiac output cannot be achieved for functional or anatomical reasons
(e.g. aortic stenosis).
Since pimobendan is metabolised mainly via the liver, it should not be used in dogs with
severe impairment of liver function. See also section 4.7.
A slight positively chronotropic effect (rise in heart rate) and vomiting can occur in rare
cases. However, these effects are dose-dependent and can be avoided by reducing the
dose.
Transient diarrhoea, anorexia or lethargy have been observed in rare cases
An increase in mitral valve regurgitation has been rarely observed during chronic
pimobendan treatment in dogs with mitral valve disease.
Signs of effects on primary haemostasis (petechiae on mucous membranes,
subcutaneous haemorrhages) may be observed during treatment in very rare cases,
although a relationship with pimobendan has not been clearly established. These signs
disappear when the treatment is withdrawn.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated-displaying adverse reactions)
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
None.

Special precautions for use in animals
Blood glucose should be tested regularly during treatment in dogs with existing diabetes
mellitus.

Revised: July 2018
AN: 01665/2017
Monitoring of cardiac function and morphology is recommended in animals treated with
pimobendan.
See also section 4.6.
The tablets are flavoured. In order to avoid any accidental ingestion, store tablets out of
reach of animals.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
In case of accidental ingestion, seek medical advice immediately and show the package
leaflet or the label to the physician.
Wash hands after use.
Advice to doctors: accidental ingestion, especially by a child may lead to the occurrence
of tachycardia, orthostatic hypotension, flushing of the face and headaches.
This product may cause cardiovascular effects in the event of accidental ingestion.
In pharmacological studies no interaction between the cardiac glycoside ouabain and
pimobendan was detected. The pimobendan-induced increase in contractility of the heart
is attenuated in the presence of the calcium antagonist verapamil and diltiazem and the
β-antagonist propranolol.
Do not store above 30°C.
Return any divided tablet to the opened blister and use within 3 days.
Not applicable.
5.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.